Security key
88025U109
10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share (TXG)
CUSIP: 88025U109
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / Class A Common Stock, $0.00001 par value per share
- Total 13F shares
- 592,608
- Total 13F value
- $51,010,340
- Share change
- -39,037
- SEC-reported price per share
- $90.36
- Number of holders
- 59
- Value change
- +$3,232,867
- Number of buys
- 28
- Number of sells
- 33
- Shares outstanding
- 120,172,375
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
59
Top holders
10
TXG full security history
Ownership snapshot
Full 13F holder table
10x Genomics, Inc. SEC filings
10x Genomics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TXG - 10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
8/15
Latest evidence
30 Sep 2026
13F
13D/G
3/4/5
Lead comparable stake: 16%
7 rows are not safely comparable across share classes.
13D/G row: FMR LLC
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 16%.
8 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
16%
PRICE T ROWE ASSOCIATES INC /MD/
12%
VANGUARD GROUP INC
12%
BlackRock, Inc.
7.6%
ARK Investment Management LLC
5.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
13D/G
Company
|
16%
Reported 13D/G
· 27 Feb 2026
|
$675,906,044
17,629,266 shares
|
— | 30 Jun 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
13F
T. Rowe Price Associates, Inc. · Company
|
12%
Reported 13D/G
· 31 Aug 2026
|
$811,042,155
14,044,020 shares
|
$0 | 31 Aug 2026 |
| VANGUARD GROUP INC |
13D/G
The Vanguard Group
|
12%
Reported 13D/G
· 30 Sep 2025
|
$155,176,941
13,274,332 shares
|
$0 | 30 Sep 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
7.6%
Reported 13D/G
· 30 Jun 2025
|
$414,228,044
10,804,070 shares
|
— | 30 Jun 2026 |
| ARK Investment Management LLC |
13D/G
13F
Company
|
5.2%
Reported 13D/G
· 30 Sep 2026
|
$566,828,099
6,272,998 shares
|
-$337,048,222 | 30 Sep 2026 |
| Sumitomo Mitsui Trust Group, Inc. |
13F
13D/G
Company
|
4.7%
Reported 13D/G
· 30 Sep 2025
|
$160,821,999
4,194,627 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
59
Shares
592,608
Rows available
59
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
392
Q3 2026 holders
59
Holder diff
-333
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|